Ophthalmic and Nasal Medication Supply for Indian Army

This tender, initiated by the Department of Military Affairs under the Ministry of Defence, represents an opportunity to supply essential ophthalmic and nasal medication to the Indian Army. The bid, identified by number GEM/2026/B/7927339, is scheduled to commence on October 10, 2026, at 7:00 PM and conclude on October 12, 2026, at 7:00 PM. The supply requirement encompasses a substantial total quantity of 16,900 units, specifically detailing a diverse range of eye drops including Brimonidine Tartrate 0.2%, Brimonidine Tartrate 0.2% with Timolol 0.5%, Clotrimazole 1% with Lignocaine 2%, Brinzolamide 1.0% with Timolol 0.5%, Bromfenac 0.09%, Cyclosporine 0.05%, Dorzolamide 2%, Flurbiprofen Sodium Ophthalmic Solution 0.03%, Nepafenac 0.1%, Prednisolone 1%, Brinzolamide 10 mg per ml, Gatifloxacin 0.3%, Latanoprost 0.005%, and Sulphacetamide 20%, alongside a significant quantity of Mometasone Nasal Spray 50 mcg per dose. Prospective bidders are advised to note the tender's origin from the Indian Army, with the governing office located in Jalandhar City, and the dated issuance of this tender being August 31, 2026.